Wall St futures flat amid US-China trade jitters; bank earnings in focus
Kua Khai Loon, a ten percent owner of Bio Green Med Solution, Inc. (NASDAQ:BGMS), sold 47,251 shares of common stock for approximately $266,790, according to a Form 4 filing with the Securities and Exchange Commission. The sales occurred in two separate transactions. The stock, which InvestingPro data shows has fallen over 90% in the past six months and currently trades at $5.13, has been experiencing significant volatility.
On September 12, 2025, Kua Khai Loon sold 22,251 shares at a price of $6.224 per share. Four days later, on September 16, 2025, the ten percent owner sold 25,000 shares at $5.132 per share. Following these transactions, Kua Khai Loon directly owns 338,160 shares of Bio Green Med Solution, Inc., which currently has a market capitalization of $15 million. InvestingPro analysis reveals the company maintains a weak financial health score of 1.57, with 12 additional key insights available to subscribers.
In other recent news, Cyclacel Pharmaceuticals, Inc. addressed concerns regarding recent stock price volatility. The company stated that it is not aware of any material developments or changes to its operating or financial condition that could explain the recent fluctuations. Cyclacel confirmed there have been no significant adverse changes to its operating results, business strategy, or future prospects beyond what has been publicly disclosed. These announcements come after a significant 270% gain in the company’s stock, followed by a 14% decline. Investors are closely monitoring the situation as Cyclacel navigates through this period of volatility. The company has reassured stakeholders by emphasizing the stability of its current operations and financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.